- Research article
- Open Access
Evidence for neuroprotective properties of human umbilical cord blood cells after neuronal hypoxia in vitro
- Susann Hau†1,
- Doreen M Reich†1Email author,
- Markus Scholz4,
- Wilfried Naumann3,
- Frank Emmrich1, 2, 5,
- Manja Kamprad†2, 5 and
- Johannes Boltze†1, 5
© Hau et al; licensee BioMed Central Ltd. 2008
- Received: 13 July 2007
- Accepted: 29 February 2008
- Published: 29 February 2008
One of the most promising options for treatment of stroke using adult stem cells are human umbilical cord blood (HUCB) cells that were already approved for therapeutic efficacy in vivo. However, complexity of animal models has thus far limited the understanding of beneficial cellular mechanisms. To address the influence of HUCB cells on neuronal tissue after stroke we established and employed a human in vitro model of neuronal hypoxia using fully differentiated vulnerable SH-SY5Y cells. These cells were incubated under an oxygen-reduced atmosphere (O2< 1%) for 48 hours. Subsequently, HUCB mononuclear cells (MNC) were added to post-hypoxic neuronal cultures. These cultures were characterized regarding to the development of apoptosis and necrosis over three days. Based on this we investigated the therapeutic influence of HUCB MNC on the progression of apoptotic cell death. The impact of HUCB cells and hypoxia on secretion of neuroprotective and inflammatory cytokines, chemokines and expression of adhesion molecules was proved.
Hypoxic cultivation of neurons initially induced a rate of 26% ± 13% of apoptosis. Hypoxia also caused an enhanced expression of Caspase-3 and cleaved poly(ADP-ribose) polymerase (PARP). Necrosis was only detected in low amounts. Within the next three days rate of apoptosis in untreated hypoxic cultures cumulated to 85% ± 11% (p ≤ 0.001). Specific cytokine (VEGF) patterns also suggest anti-apoptotic strategies of neuronal cells. Remarkably, the administration of MNC showed a noticeable reduction of apoptosis rates to levels of normoxic control cultures (7% ± 3%; p ≤ 0.001). In parallel, clustering of administered MNC next to axons and somata of neuronal cells was observed. Furthermore, MNC caused a pronounced increase of chemokines (CCL5; CCL3 and CXCL10).
We established an in vitro model of neuronal hypoxia that affords the possibility to investigate both, apoptotic neuronal cell death and neuroprotective therapies. Here we employed the therapeutic model to study neuroprotective properties of HUCB cells.
We hypothesize that the neuroprotective effect of MNC was due to anti-apoptotic mechanisms related to direct cell-cell contacts with injured neuronal cells and distinct changes in neuroprotective, inflammatory cytokines as well as to the upregulation of chemokines within the co-cultures.
- Neuronal Cell
- Human Umbilical Cord Blood
- Necrosis Rate
- Specific Neuronal Marker
- Organotypic Hippocampal Slice Culture
Acute ischemic stroke is characterised by the immediate depletion of oxygen and glucose in brain tissue. A residual cerebral blood flow (CBF) of ≤ 6 cm3 × 100 g-1 × min-1 representing severe ischemia is associated with a nearly total loss of energy on vulnerable neurons. Ischemia therefore rapidly culminates in the formation of a necrotic core . In the penumbra, mild ischemia (CBF 11–20 cm3 × 100 g-1 × min-1) leads to the activation of complex neurochemical cascades of cell death, mainly apoptosis. In principle these apoptotic cascades are reversible and form an important aspect of the penumbra concept, which is the major target of therapeutic interventions [2, 3]. Recent findings indicate that transplantation of external cell fractions could accompany established therapeutic procedures limited by narrow time windows , but the underlying processes are still rather unclear.
Our insights into pathophysiological processes and new therapeutic strategies have mostly been obtained from animal models of focal cerebral ischemia [5, 6] and rodent organotypic hippocampal slice cultures [7–9]. However, the complexity of those systems has limited the detailed understanding of mechanisms related to ischemic brain injury  and possible interfering effects of cellular therapies  so far. Furthermore, results obtained from rodent models are not completely and unobjectionably transferable to human therapy [12, 13]. Consequently, experimental expenditure and ethical considerations demand in vitro models representing the main properties of stroke-related processes as neuronal apoptosis to accompany more complex model systems. This would allow to answer explicit questions concerning the role of cell-cell interactions and production of metabolites to verify observations made in in vivo models. It furthermore offers the possibility to precisely manipulate extra cellular environments.
Well described human neuronal cell lines exhibit a multitude of characteristics of typical central-nervous-system (CNS) neurons, overall cell material can be achieved in large quantities. Therefore, human neuronal cell lines, such as the teratocarcinoma NT-2 cell line, became useful tools to study the effects of hypoxic conditions on neurons . However, the utilisation of NT-2 neuronal cultures is restricted by time-consuming and expensive differentiation periods of up to 44–54 days [15, 16] that are also sensitive to environmental disturbances. In contrast, the SH-SY5Y neuroblastoma cell line was shown to be differentiated into neuronal cells within a comparatively short time of 16 days . Furthermore, the cell line fits major relevant criteria (high vulnerability, irreversible differentiation into pure neuronal cells) to serve as a model of hypoxic injury of central neurons . Hence, our exclusive human model of neuronal hypoxia forms the basis to identify possible anti-apoptotic neuroprotective potentials of therapeutic supplements. Mononuclear cells (MNC) from human umbilical cord blood (HUCB) were shown to improve functional outcome of animals after focal cerebral ischemia. The cellular effects causing the observed benefits are not fully understood for these cells [19, 20]. In this context we investigated whether injured post-hypoxic neuronal cells or MNC initiated an anti-apoptotic response mediated by cytokines or chemokines.
After differentiation SH-SY5Y exhibited neuronal morphology and specific neuronal markers
Absence of proliferation after termination of differentiation
Hypoxia induced apoptosis in the majority of neuronal cells
In general, an increased release of calcein-AM also indicated a strong decrease of neuronal cell viability which verifies the results of the apoptosis and necrosis rates (data not shown).
Hypoxia increased quantities of Caspase-3 and cleaved PARP immediately and secretion of VEGF in delay
Adhesion molecules (L1, NCAM and ICAM-1) were upregulated after hypoxia
Co-culturing with HUCB MNC strongly reduced apoptosis in post-hypoxic neuronal cell cultures
MNC increased CCL5, CCL3, CCL4 and CXCL10 in post-hypoxic neuronal cultures
The investigation of neuroprotective cytokines (G-CSF, VEGF) (Fig. 7A), inflammatory cytokines (IL-1β, IL-6, CXCL8) (Fig. 7B) and chemokines (CCL2, CCL5, CCL3, CCL4, CXCL10) (Fig. 7C) in supernatants of normoxic neuronal cultures revealed considerable amounts of CXCL8, CCL2 and VEGF. Remarkably, after three days under hypoxic conditions only VEGF was strongly upregulated (about threefold increase). After administration of MNC, VEGF was downregulated regarding to the total concentration measured in mono-cultures of MNC and in post-hypoxic neuronal cells. Inflammatory cytokines as IL-1β, IL-6 and CXCL8 were produced by MNC. The secretion of cytokines such as IL-1β and IL-6 was not altered in post-hypoxic co-cultures, whereas CXCL8 was suppressed. Interestingly, the majority of chemokines was clearly upregulated in co-cultures with MNC. We could show that CCL5, CCL3, CCL4 and CXCL10 were increased up to the tenfold (CCL3, CCL4), whereas the concentration CCL2 was not regulated.
In this study, we introduce an experimental human in vitro model to investigate (i) the mechanisms of neuronal hypoxia and (ii) the interaction of neuronal cells with external stem cell-containing fractions as possible therapeutic tools. According to the differentiation protocol of Encinas et al.  we obtained fully matured neuronal cells after 16 days. Previous, orientating experiments showed typical response of differentiated SH-SY5Y cells to N-methyl-D-aspartate (NMDA; 300 μM) application and most pronounced vulnerability after 48 hours hypoxic incubation (data not shown). These post-hypoxic neuronal cultures can be employed already 18 days after the seeding of naive cells. Therefore the time period until the model of hypoxic neuronal cells is available is very short. In comparison to other approaches that provide assimilable hypoxic models using teratocarcinoma cell lines  the generation of our model is shortened by at least 10 days . The proved expression of specific neuronal markers and the absence of any proliferation gave clear evidence of matured neuronal cells in the G0-phase of the cell cycle. This steady state allows making direct conclusions about the influence of any external manipulation because any change will most probably be due to these procedures. Hence, the model of neuronal hypoxia affords the possibility to investigate manifold questions concerning mechanisms triggered in response to hypoxia and therapeutic interventions e.g. application of HUCB MNC.
Following hypoxia, neuronal cultures displayed a correlation between morphological changes and increase of annexin-V positive cells as well as changes in adhesion molecule expression. The specific apoptosis marker annexin-V indicated that hypoxic cultivation preferentially induced apoptosis. Moreover, there was a continuous enlargement in number of apoptotic cells from initial 26% ± 13% until cultures almost completely consisted of apoptotic cells (85% ± 11%) within three days. Conforming to changes of morphology in post-hypoxic cultures, there was an enhanced release of calcein-AM also observable due to the loss of the integrity of membrane. This is typical for late stages of apoptosis as well as of necrosis. The model of neuronal hypoxia was approved by moderate rates of PI positive cells (23% ± 16% at Day 3 post-hypoxia). Therefore the overrun of 100% by the summation of annexin-V positive and PI positive cells is due to a proportion of cells in a late state of apoptosis that are positive for annexin-V and PI . We focused on apoptosis because it is a reversible process which could be modulate by external stimulation [23, 24]. Moreover after stroke cell death in the penumbra is predominantly considered to be apoptosis [25–28]. Therefore apoptosis is a therapeutic target of anti-apoptotic therapies like stem cells or cytokines [29–32].
Apoptosis in the penumbra takes place in a time span of about 72 hours after vessel occlusion in the rat after middle cerebral artery occlusion (MCAO) . This time course is represented by the model system introduced in this study. The fact that there was no major alteration in the number in DAPI-positive nuclei underlines that the influence of hypoxia did not lead to an immediate destruction of the cells but allows investigating apoptosis and subsequent therapeutic interventions within 72 hours. These facts were also confirmed by characteristic changes in the morphology of post-hypoxic cells. There was a total retraction of dendrites and a resulting destruction of neuronal networks, grained cell surfaces and extended cell degradation. This damage was accompanied by an upregulation of neuronal adhesion molecules. We hypothesize that this upregulation indicates a cellular answer to compensate for a loss of direct cell-cell interaction as a consequence of the preceding hypoxic stress as described by several authors [34–36]. However, the final loss of intercellular networks could not be compensated by the increased expression of neuronal adhesion molecules alone.
Neuronal cell death after hypoxia is caused by membrane depolarisation subsequent to energy failure [37, 38]. The resulting calcium overload is the initial point of the activation of manifold biochemical pathways that affect caspases, free radicals and gene expression [39, 40]. The specific apoptotic proteins Caspase-3 and cleaved PARP were quantified to prove whether our microscopic observations are corroborated by biochemical pathways [41–43]. After 24 hours post-hypoxia, both marker proteins extensively increased. This was followed by a sharp drop in their expression level. This reduced amount of cleaved PARP might be due to an aggravating energy failure in the cell. This in turn is attributed to the high levels of cleaved PARP, evidenced above, which caused adenosintriphosphate (ATP) depletion [44, 45] and which in this context prevents the enzymatic activity of caspases. Furthermore, an increase of the expression of VEGF, a key mediator of angiogenesis [46, 47], was observed in higher concentrations in late post-hypoxic cultures. This might be a reflection of compensatory in vivo processes of revascularisation in our model [48, 49]. VEGF is also known to be involved in neuronal protection through inhibition of Caspase-3 [50, 51]. The time-delayed increased release of VEGF as an effect of hypoxia does not seem to influence the number of apoptotic cells in our cultures. This may be a result of concentrations of VEGF that did not reach efficient thresholds. In this context the measured reduction of caspases on Days 2 and 3 after hypoxia is caused by the already described ongoing energy failure in the post-hypoxic cells. However, the regulation of those apoptotic proteins is probably not related to VEGF mediated-effects.
The therapeutic benefit of cell administration after stroke has been demonstrated in numerous animal studies [52, 53]. However, important questions in basic cellular and molecular mechanisms of neuronal cell death and its prevention after inadequate oxygen supply still remain unanswered. To understand the mechanisms of cellular neuroprotection after stroke we employed the model of neuronal hypoxia and applied MNC from HUCB.
In vivo MNC are supposed to differentiate into neuronal cells [54, 55] to trophically support neuronal tissue through the production of growth factors , to support the new formation of synapses and migration as well as the differentiation of endogenous neuronal progenitors [54, 55]. In our experiments, the administration of MNC from HUCB to post-hypoxic neuronal cultures showed remarkable beneficial effects. Over three days we could show a clear reduction of neuronal apoptosis, even to the level of normoxic control cultures (7% ± 3%). There are two observations that contribute to an explanation of neuroprotective mechanisms. First, MNC were preferentially located close to hypoxically injured neuronal cells. This phenomenon was facilitated through an intensive upregulation of ICAM-1 on neuronal cells which is the specific ligand for leukocyte cell adhesion molecule [LFA-1] expressed by all immune cell subsets . However, the formation of cell chimera was not observed, as there were no CFSE-stained cells with neuronal morphology. In future experiments we will investigate whether blocking of adhesion molecules on the surface of neuronal cells can inhibit the co-localisation of MNC. Further it will be proved whether this influences the rate of apoptosis. An increase of apoptosis would be an evidence for the significance of direct cell-cell-contacts in context of therapeutic mechanisms of MNC. The second observation would be concomitance of an MNC indicated specific alteration in levels of soluble factors. That change might be held responsible for neuroprotection. Pronounced upregulation of chemokines (CCL5, CCL3, CCL4, CXCL10) might be causal for the enhanced effort of MNC to localise near neuronal structures. High concentrations of VEGF are known to be neuroprotective [58, 59]. In contrast to post-hypoxic mono-cultures, we found no increase of VEGF after administration of MNC. It seems that presence of MNC inhibited the induction of elevated levels of VEGF and compensated its neuroprotective effects by other mechanisms. Cord blood contains distinct cell types capable to differentiate into neuronal cells . However, the differentiation of stem cells (about 1% within the MNC fraction) was not expected because of the short time of co-cultivation that clearly undershoots time frames responsible for neuronal differentiation.
So far, it is unclear whether neuroprotection resulted from one of the observed effects or from a combination of spatial proximity and specific cytokine patterns. Consequently, further studies in indirect co-cultures will be necessary.
Pathophysiological models developed from animal studies form the basis of our understanding of the development of stroke. In vivo data display a perfusion-related dependency of neuronal cell damage. Residual energy supply in the penumbra induces apoptosis, the early phases of which are reversible. Consequently, rescue of the penumbra is a major target of experimental stroke therapy. Data obtained from complex animal models of stroke strongly suggest that transplanted cells enhance neuronal survival.
We established a standardized human in vitro model of neuronal apoptotic cell death after hypoxia that can facilitate to address specific pathophysiological processes underlying hypoxic damage and cell-mediated neuroprotection more precisely.
Interestingly, transplanted MNC not only strongly decreased the ratio of apoptosis in neuronal cells but also triggered retaining neuronal characteristics such as forming networks. MNC clustered around post-hypoxic neuronal cells and induced an alteration in cytokine and chemokine concentrations. Our data suggest that the neuroprotective effects of MNC might result from direct cell-cell contacts and/or the adjustment of specific soluble mediators.
Cultivation and differentiation of neuronal cells
Composition of culture media
Supplements in DMEM
Day of culture
Description of media
RA (10 μM)
BDNF (5 ng/ml)
Maintenance medium (MM)
1 – 4
Basic medium (BM)
5 – 16
Differentiation medium (DM)
16 – 18
Differentiation medium (DM)
18 – 21
Post-hypoxic medium (PHM)
Immunocytofluorescence of neuronal markers
The primary antibodies used against neuronal epitopes were: β-tubulin III (rabbit 10 μg/ml; BD PharMingen, Heidelberg, Germany), taurin I and neurofilament (NF) H/M (rabbit 5 μg/ml and mouse 1:200; Chemicon, Hampshire, UK), neuron-specific enolase (NSE) and microtubule-associated proteins (Map) 2a/b (mouse 1:2 and mouse 5 μg/ml; Sigma-Aldrich, Munich, Germany). Fluorochrome-conjugated secondary antibodies were purchased from DAKO, Carpinteria, CA, USA (goat anti-mouse-PE [1:200] and pork anti-rabbit-FITC [1:30]). Indirect immunostaining was processed according to manufacturer's instructions.
Hypoxia and post-hypoxic cultivation
Before enddifferentiated neuronal cells were exposed to hypoxia they were refreshed with DM. Hypoxic conditions were O2 < 1% (oxygen substituted with nitrogen) and lasted 48 hours in a 37°C tempered and humidified incubator (Binder GmbH, Tuttlingen). After hypoxia, cultures were supplied with PHM (Table 1) and were transferred back to normoxic conditions for the following three days (Fig. 10).
Quantification of cell numbers by nuclear staining
The total number of cells was measured by nuclear staining with 4', 6-diamidino-2-phenylindole (DAPI, Invitrogen, Karlsruhe, Germany). Cells were washed and stained with 1 μg/ml (DAPI/Methanol) for 15 minutes at 37°C. 25 microphotographs of randomised fields were taken per cavity using a Zeiss fluorescence microscope (Carl Zeiss AG, Jena, Germany) equipped with Zeiss AxioVision-Software. The number of nuclei was automatically determined by means of Zeiss AutMess (Carl Zeiss AG, Jena, Germany).
Cell viability assay
Apoptosis was determined via annexin-fluorescein isothiocyanate (FITC) or annexin-phycoerythrin (PE; both 1:20 reaction buffer; BD PharMingen, Heidelberg, Germany) using fluorescence microscopy. Necrosis was identified by propidium iodide (PI) staining (1 μg/ml phosphate-buffered saline [PBS]; Bender medSystems, Vienna, Austria). Both methods detect cells in a late state of apoptosis. Apoptosis and necrosis were ascertained in different cavities. Calcein-AM (40 μM/PBS; Invitrogen, Karlsruhe, Germany) was utilised for detection of living cells.
Quantification of apoptotic proteins
BD Cytometric Bead Array for human apoptosis (Becton Dickinson, Erembodegem, Belgium) was used for the quantitative measurement of apoptotic proteins (cleaved PARP and Caspase-3). Manufacturer' s instructions were adapted to lyse cells directly within multi-well plates. For cell lyses differentiated cells were rinsed with PBS and incubated on ice in the provided buffer for 20 minutes.
Determination of adhesion molecules by immunocytochemistry and cell-based fluorescence measurement
The cultures were stained with antibodies against CD56-phycoerythrin (PE; NCAM), CD171 (L1, both Becton Dickinson, Erembodegem, Belgium), CD54-PE (ICAM-1; Immunotech, Hamburg, Germany) and CD106-PE (VCAM-1; Southern Biotech, Birmingham, Alabama, USA) in order to investigate the distribution and localisation of adhesion molecules on differentiated neuronal cells. The staining protocol proceeded as follows: Medium (DM, Table 1) was removed and dishes were washed twice with PBS. The cells were incubated with primary labelled or unlabelled antibodies (1:100) for 10 minutes at 37°C and afterwards washed in PBS. Thereafter the cells were incubated with goat anti-mouse-PE (DAKO, Hamburg, Germany) antibody for 10 minutes at 37°C for CD171 detection. After labelling the cultures were immersed in PBS.
The spatial distribution of adhesion molecules was observed using fluorescence microscopy (Carl Zeiss AG, Jena, Germany). The density of molecule expression was measured in cell lysates. Therefore, antibody-labelled cultures were treated with 1% Triton × 100 (Ferak, Berlin, Germany)/PBS at 37°C. Whole-cell lysates were transferred to black 96-well-plates (Greiner Bio-One, Frickenhausen, Germany). PE-fluorescence signals were determined with a spectrafluorometer (Tecan Spectrafluor Plus, Tecan Trading AG, Switzerland) at an excitation wavelength of 488 nm and an emission wavelength of 590 nm. Specific isotypes and 1% Triton × 100 served as negative controls.
Preparation of Human Umbilical Cord Blood (HUCB) samples
Cord blood samples were obtained anonymously in accordance to ethical prescripts immediately after delivery. HUCB samples of healthy full-term neonates were processed according experienced methods including density gradient separation using Lymphocyte Separation Medium (PAA Laboratories, Cölbe, Germany). Gained MNC fraction was stored by freezing in the gaseous phase of liquid nitrogen after the addition of FCS/8% dimethyl sulfoxide (Serumwerke Bernburg Inc., Bernburg, Germany). Prior to use cryopreserved MNC were thawed rapidly in 75 U/ml DNaseI/0.5 M MgCl2 (Roche Diagnostics GmbH, Mannheim, Germany/Sigma, Germany) and washed in RPMI (PAA Laboratories, Austria). Cell suspension was stained with carboxy fluoresceindiacetate succinimidyl ester (CFSE 5 μM; Molecular Probes, Inc., Eugene, OR, USA) for 10 minutes at 37°C.
Co-culture of neuronal cells and MNC
Direct co-culturing of fully differentiated neuronal cells and MNC was carried out under normoxic conditions (37°C) over a period of 3 days following 48 hours of hypoxia. A total amount of 4.5 × 105 CFSE stained MNC were dissolved in 500 μl PHM and were added to the post-hypoxic neuronal cells (0.3 × 105/cavity). The ratio of neuronal cells to MNC was 1:15.
The supernatants from normoxic cultures on Day 21 as well as from hypoxic cultures on Day 3 post-hypoxia were collected in order to characterise soluble factors produced by cultured cells. They were detected simultaneously by means of Becton Dickinson Cytometric Bead Array. Supernatants were tested for neuroprotective (Granulocyte Colony-Stimulating Factor [G-CSF], Vascular Endothelial Growth Factor [VEGF]) and inflammatory cytokines (Interleukin [IL]-1β, IL-6, CXCL8) as well as chemokines (CXCL10, CCL3, CCL4, CCL5, CCL2). The detection limit was 0.02 ng/ml, except for VEGF and CCL2 (0.04 ng/ml).
Statistical analyses of data
Except for apoptosis and necrosis rates all results have been reported as mean values ± SD. Statistical differences were analysed by the Student s t-test or the Mann-Whitney rank sum-test. P values of ≤ 0.05 were considered statistically significant (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001). Apoptosis and necrosis rates were logit-transformed to obtain normally distributed quantities. The effects of time, experimental setting (hypoxia), experimental run and the investigated cavity were determined univariately, and, finally multivariately using a mixed-model approach with time and experimental setting as fixed effects and cavity and experimental run as random effects. Cytokine concentrations were compared between the normoxic and the hypoxic group by means of the Mann-Whitney rank sum test. Cytokine concentrations measured in co-cultures were compared with the sum of the concentrations obtained in the post-hypoxic neuronal cultures and in the MNC mono-cultures via a bootstrapping algorithm. This was performed by resampling and by the addition of concentrations of cytokines measured in post-hypoxic neuronal cultures and MNC mono- cultures. Results were compared with the Mann-Whitney rank sum test. The mean and standard deviations of the sum of the concentrations were also determined by bootstrapping. Bootstrapping analysis was performed using the statistical software package "R" [61, 62]. Mixed-model analyses were performed using PROC MIXED from the statistical software package SAS 9.1 (SAS Institute Inc., Cary, NC, USA). Box plots (if applicable) and univariate analyses were determined using the software package SPSS (SPSS Inc., Chicago IL, USA).
This study was supported by the Development Bank of Saxony (SAB).
- Kaufmann AM, Firlik AD, Fukui MB, Wechsler LR, Jungries CA, Yonas H: Ischemic core and penumbra in human stroke. Stroke. 1999, 30: 93-99.View ArticlePubMedGoogle Scholar
- Kato H, Kogure K: Biochemical and molecular characteristics of the brain with developing cerebral infarction. Cell Mol Neurobiol. 1999, 19: 93-108. 10.1023/A:1006920725663.View ArticlePubMedGoogle Scholar
- Saito A, Maier CM, Narasimhan P, Nishi T, Song YS, Yu F, Liu J, Lee YS, Nito C, Kamada H, Dodd RL, Hsieh LB, Hassid B, Kim EE, Gonzalez M, Chan PH: Oxidative stress and neuronal death/survival signaling in cerebral ischemia. Mol Neurobiol. 2005, 31: 105-116. 10.1385/MN:31:1-3:105.View ArticlePubMedGoogle Scholar
- Newcomb JD, Ajmo CT, Sanberg CD, Sanberg PR, Pennypacker KR, Willing AE: Timing of cord blood treatment after experimental stroke determines therapeutic efficacy. Cell Transplant. 2006, 15: 213-223. 10.3727/000000006783982043.View ArticlePubMedGoogle Scholar
- Ahmed SH, Shaikh AY, Shaikh Z, Hsu CY: What animal models have taught us about the treatment of acute stroke and brain protection. Curr Atheroscler Rep. 2000, 2: 167-180. 10.1007/s11883-000-0112-2.View ArticlePubMedGoogle Scholar
- Mergenthaler P, Dirnagl U, Meisel A: Pathophysiology of stroke: lessons from animal models. Metab Brain Dis. 2004, 19: 151-167. 10.1023/B:MEBR.0000043966.46964.e6.View ArticlePubMedGoogle Scholar
- Lewczuk P, Hasselblatt M, Kamrowski-Kruck H, Heyer A, Unzicker C, Siren AL, Ehrenreich H: Survival of hippocampal neurons in culture upon hypoxia: effect of erythropoietin. Neuroreport. 2000, 11: 3485-3488. 10.1097/00001756-200011090-00017.View ArticlePubMedGoogle Scholar
- Laskowski A, Schmidt W, Dinkel K, Martinez-Sanchez M, Reymann KG: bFGF and EGF modulate trauma-induced proliferation and neurogenesis in juvenile organotypic hippocampal slice cultures. Brain Res. 2005, 1037: 78-89. 10.1016/j.brainres.2004.12.035.View ArticlePubMedGoogle Scholar
- Choi Y, McClain MA, LaPlaca MC, Frazier AB, Allen MG: Three dimensional MEMS microfluidic perfusion system for thick brain slice cultures. Biomed Microdevices. 2007, 9: 7-13. 10.1007/s10544-006-9004-8.View ArticlePubMedGoogle Scholar
- Traystman RJ: Animal models of focal and global cerebral ischemia. ILAR J. 2003, 44: 85-95.View ArticlePubMedGoogle Scholar
- Haas S, Weidner N, Winkler J: Adult stem cell therapy in stroke. Curr Opin Neurol. 2005, 18: 59-64. 10.1097/00019052-200502000-00012.View ArticlePubMedGoogle Scholar
- Heiss WD: Stroke--acute interventions. J Neural Transm Suppl. 2002, 37-57.Google Scholar
- Heiss WD, Thiel A, Winhuisen L, Muhlberger B, Kessler J, Herholz K: Functional imaging in the assessment of capability for recovery after stroke. J Rehabil Med. 2003, 27-33. 10.1080/16501960310010115.Google Scholar
- Rootwelt T, Dunn M, Yudkoff M, Itoh T, Almaas R, Pleasure D: Hypoxic cell death in human NT2-N neurons: involvement of NMDA and non-NMDA glutamate receptors. J Neurochem. 1998, 71: 1544-1553.View ArticlePubMedGoogle Scholar
- Paquet-Durand F, Tan S, Bicker G: Turning teratocarcinoma cells into neurons: rapid differentiation of NT-2 cells in floating spheres. Brain Res Dev Brain Res. 2003, 142: 161-167. 10.1016/S0165-3806(03)00065-8.View ArticlePubMedGoogle Scholar
- Pleasure SJ, Page C, Lee VM: Pure, postmitotic, polarized human neurons derived from NTera 2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons. J Neurosci. 1992, 12: 1802-1815.PubMedGoogle Scholar
- Encinas M, Iglesias M, Liu Y, Wang H, Muhaisen A, Cena V, Gallego C, Comella JX: Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells. J Neurochem. 2000, 75: 991-1003. 10.1046/j.1471-4159.2000.0750991.x.View ArticlePubMedGoogle Scholar
- Lopez E, Ferrer I: Staurosporine- and H-7-induced cell death in SH-SY5Y neuroblastoma cells is associated with caspase-2 and caspase-3 activation, but not with activation of the FAS/FAS-L-caspase-8 signaling pathway. Brain Res Mol Brain Res. 2000, 85: 61-67. 10.1016/S0169-328X(00)00235-7.View ArticlePubMedGoogle Scholar
- Chen SH, Chang FM, Tsai YC, Huang KF, Lin CL, Lin MT: Infusion of human umbilical cord blood cells protect against cerebral ischemia and damage during heatstroke in the rat. Exp Neurol. 2006, 199: 67-76. 10.1016/j.expneurol.2005.11.015.View ArticlePubMedGoogle Scholar
- Vendrame M, Cassady J, Newcomb J, Butler T, Pennypacker KR, Zigova T, Sanberg CD, Sanberg PR, Willing AE: Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume. Stroke. 2004, 35: 2390-2395. 10.1161/01.STR.0000141681.06735.9b.View ArticlePubMedGoogle Scholar
- Paquet-Durand F, Bicker G: Hypoxic/ischaemic cell damage in cultured human NT-2 neurons. Brain Res. 2004, 1011: 33-47. 10.1016/j.brainres.2004.02.060.View ArticlePubMedGoogle Scholar
- Stroh A, Zimmer C, Gutzeit C, Jakstadt M, Marschinke F, Jung T, Pilgrimm H, Grune T: Iron oxide particles for molecular magnetic resonance imaging cause transient oxidative stress in rat macrophages. Free Radic Biol Med. 2004, 36: 976-984. 10.1016/j.freeradbiomed.2004.01.016.View ArticlePubMedGoogle Scholar
- Ferrer I: Apoptosis: future targets for neuroprotective strategies. Cerebrovasc Dis. 2006, 21 (Suppl 2): 9-20. 10.1159/000091699.View ArticlePubMedGoogle Scholar
- Fisher M: The ischemic penumbra: a new opportunity for neuroprotection. Cerebrovasc Dis. 2006, 21 (Suppl 2): 64-70. 10.1159/000091705.View ArticlePubMedGoogle Scholar
- Ferrer I, Friguls B, Dalfo E, Justicia C, Planas AM: Caspase-dependent and caspase-independent signalling of apoptosis in the penumbra following middle cerebral artery occlusion in the adult rat. Neuropathol Appl Neurobiol. 2003, 29: 472-481. 10.1046/j.1365-2990.2003.00485.x.View ArticlePubMedGoogle Scholar
- Stefanis L: Caspase-dependent and -independent neuronal death: two distinct pathways to neuronal injury. Neuroscientist. 2005, 11: 50-62. 10.1177/1073858404271087.View ArticlePubMedGoogle Scholar
- Nishioka T, Nakase H, Nakamura M, Konishi N, Sakaki T: Sequential and spatial profiles of apoptosis in ischemic penumbra after two-vein occlusion in rats. J Neurosurg. 2006, 104: 938-944. 10.3171/jns.2006.104.6.938.View ArticlePubMedGoogle Scholar
- Hossmann KA: Pathophysiology and therapy of experimental stroke. Cell Mol Neurobiol. 2006, 26: 1057-1083. 10.1007/s10571-006-9008-1.View ArticlePubMedGoogle Scholar
- Schneider A, Wysocki R, Pitzer C, Kruger C, Laage R, Schwab S, Bach A, Schabitz WR: An extended window of opportunity for G-CSF treatment in cerebral ischemia. BMC Biol. 2006, 4: 36-10.1186/1741-7007-4-36.PubMed CentralView ArticlePubMedGoogle Scholar
- Chang YC, Shyu WC, Lin SZ, Li H: Regenerative therapy for stroke. Cell Transplant. 2007, 16: 171-181.PubMedGoogle Scholar
- Shyu WC, Lee YJ, Liu DD, Lin SZ, Li H: Homing genes, cell therapy and stroke. Front Biosci. 2006, 11: 899-907. 10.2741/1846.View ArticlePubMedGoogle Scholar
- Cairns K, Finklestein SP: Growth factors and stem cells as treatments for stroke recovery. Phys Med Rehabil Clin N Am. 2003, 14: S135-S142.View ArticlePubMedGoogle Scholar
- Xu XH, Zhang SM, Yan WM, Li XR, Zhang HY, Zheng XX: Development of cerebral infarction, apoptotic cell death and expression of X-chromosome-linked inhibitor of apoptosis protein following focal cerebral ischemia in rats. Life Sci. 2006, 78: 704-712. 10.1016/j.lfs.2005.05.080.View ArticlePubMedGoogle Scholar
- Aubert I, Ridet JL, Gage FH: Regeneration in the adult mammalian CNS: guided by development. Curr Opin Neurobiol. 1995, 5: 625-635. 10.1016/0959-4388(95)80068-9.View ArticlePubMedGoogle Scholar
- Holm J, Appel F, Schachner M: Several extracellular domains of the neural cell adhesion molecule L1 are involved in homophilic interactions. J Neurosci Res. 1995, 42: 9-20. 10.1002/jnr.490420103.View ArticlePubMedGoogle Scholar
- Martini R, Schachner M: Immunoelectron microscopic localization of neural cell adhesion molecules (L1, N-CAM, and myelin-associated glycoprotein) in regenerating adult mouse sciatic nerve. J Cell Biol. 1988, 106: 1735-1746. 10.1083/jcb.106.5.1735.View ArticlePubMedGoogle Scholar
- Hou ST, MacManus JP: Molecular mechanisms of cerebral ischemia-induced neuronal death. Int Rev Cytol. 2002, 221: 93-148.View ArticlePubMedGoogle Scholar
- Smith WS: Pathophysiology of focal cerebral ischemia: a therapeutic perspective. J Vasc Interv Radiol. 2004, 15: S3-12.View ArticlePubMedGoogle Scholar
- Valencia I, Mishra OP, Zubrow A, Fritz K, Katsetos CD, ivoria-Papadopoulos M, Legido A: [The role played by calcium in neuronal injury following neonatal hypoxia or convulsions.]. Rev Neurol. 2006, 42 (Suppl 3): S11-S15.PubMedGoogle Scholar
- White BC, Sullivan JM, DeGracia DJ, O'Neil BJ, Neumar RW, Grossman LI, Rafols JA, Krause GS: Brain ischemia and reperfusion: molecular mechanisms of neuronal injury. J Neurol Sci. 2000, 179: 1-33. 10.1016/S0022-510X(00)00386-5.View ArticlePubMedGoogle Scholar
- Prunell GF, Arboleda VA, Troy CM: Caspase function in neuronal death: delineation of the role of caspases in ischemia. Curr Drug Targets CNS Neurol Disord. 2005, 4: 51-61. 10.2174/1568007053005082.View ArticlePubMedGoogle Scholar
- Zheng Z, Zhao H, Steinberg GK, Yenari MA: Cellular and molecular events underlying ischemia-induced neuronal apoptosis. Drug News Perspect. 2003, 16: 497-503. 10.1358/dnp.2003.16.8.829348.View ArticlePubMedGoogle Scholar
- Ferrer I, Friguls B, Dalfo E, Justicia C, Planas AM: Caspase-dependent and caspase-independent signalling of apoptosis in the penumbra following middle cerebral artery occlusion in the adult rat. Neuropathol Appl Neurobiol. 2003, 29: 472-481. 10.1046/j.1365-2990.2003.00485.x.View ArticlePubMedGoogle Scholar
- Sugawara T, Fujimura M, Noshita N, Kim GW, Saito A, Hayashi T, Narasimhan P, Maier CM, Chan PH: Neuronal death/survival signaling pathways in cerebral ischemia. NeuroRx. 2004, 1: 17-25. 10.1602/neurorx.1.1.17.PubMed CentralView ArticlePubMedGoogle Scholar
- Endres M, Wang ZQ, Namura S, Waeber C, Moskowitz MA: Ischemic brain injury is mediated by the activation of poly(ADP-ribose) polymerase. J Cereb Blood Flow Metab. 1997, 17: 1143-1151. 10.1097/00004647-199711000-00002.View ArticlePubMedGoogle Scholar
- Greenberg DA: Angiogenesis and stroke. Drug News Perspect. 1998, 11: 265-270. 10.1358/dnp.1918.104.22.1687287.View ArticlePubMedGoogle Scholar
- Schoch HJ, Fischer S, Marti HH: Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain. Brain. 2002, 125: 2549-2557. 10.1093/brain/awf257.View ArticlePubMedGoogle Scholar
- Marti HH, Risau W: Angiogenesis in ischemic disease. Thromb Haemost. 1999, 82 (Suppl 1): 44-52.PubMedGoogle Scholar
- Namiecinska M, Marciniak K, Nowak JZ: [VEGF as an angiogenic, neurotrophic, and neuroprotective factor]. Postepy Hig Med Dosw (Online). 2005, 59: 573-583.Google Scholar
- Gora-Kupilas K, Josko J: The neuroprotective function of vascular endothelial growth factor (VEGF). Folia Neuropathol. 2005, 43: 31-39.PubMedGoogle Scholar
- Jin K, Mao XO, Batteur SP, McEachron E, Leahy A, Greenberg DA: Caspase-3 and the regulation of hypoxic neuronal death by vascular endothelial growth factor. Neuroscience. 2001, 108: 351-358. 10.1016/S0306-4522(01)00154-3.View ArticlePubMedGoogle Scholar
- Chen J, Li Y, Wang L, Lu M, Zhang X, Chopp M: Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats. J Neurol Sci. 2001, 189: 49-57. 10.1016/S0022-510X(01)00557-3.View ArticlePubMedGoogle Scholar
- Christensen T, Wienrich M, Ensinger HA, Diemer NH: The broad-spectrum cation channel blocker pinokalant (LOE 908 MS) reduces brain infarct volume in rats: a temperature-controlled histological study. Basic Clin Pharmacol Toxicol. 2005, 96: 316-324. 10.1111/j.1742-7843.2005.pto960407.x.View ArticlePubMedGoogle Scholar
- Chu K, Kim M, Jung KH, Jeon D, Lee ST, Kim J, Jeong SW, Kim SU, Lee SK, Shin HS, Roh JK: Human neural stem cell transplantation reduces spontaneous recurrent seizures following pilocarpine-induced status epilepticus in adult rats. Brain Res. 2004, 1023: 213-221. 10.1016/j.brainres.2004.07.045.View ArticlePubMedGoogle Scholar
- Taguchi A, Soma T, Tanaka H, Kanda T, Nishimura H, Yoshikawa H, Tsukamoto Y, Iso H, Fujimori Y, Stern DM, Naritomi H, Matsuyama T: Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest. 2004, 114: 330-338.PubMed CentralView ArticlePubMedGoogle Scholar
- Chen J, Sanberg PR, Li Y, Wang L, Lu M, Willing AE, Sanchez-Ramos J, Chopp M: Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke. 2001, 32: 2682-2688. 10.1161/hs1101.098367.View ArticlePubMedGoogle Scholar
- Giblin PA, Lemieux RM: LFA-1 as a key regulator of immune function: approaches toward the development of LFA-1-based therapeutics. Curr Pharm Des. 2006, 12: 2771-2795. 10.2174/138161206777947731.View ArticlePubMedGoogle Scholar
- Sun Y, Jin K, Xie L, Childs J, Mao XO, Logvinova A, Greenberg DA: VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest. 2003, 111: 1843-1851.PubMed CentralView ArticlePubMedGoogle Scholar
- Wang Y, Galvan V, Gorostiza O, Ataie M, Jin K, Greenberg DA: Vascular endothelial growth factor improves recovery of sensorimotor and cognitive deficits after focal cerebral ischemia in the rat. Brain Res. 2006, 1115: 186-193. 10.1016/j.brainres.2006.07.060.View ArticlePubMedGoogle Scholar
- Arien-Zakay H, Nagler A, Galski H, Lazarovici P: Neuronal conditioning medium and nerve growth factor induce neuronal differentiation of collagen-adherent progenitors derived from human umbilical cord blood. J Mol Neurosci. 2007, 32: 179-191. 10.1007/s12031-007-0027-2.View ArticlePubMedGoogle Scholar
- The R Project for Statistical Computing. [http://www.r-project.org/]
- Ihaka R, Gentleman R: R a language for data analysis and graphics. J Comp Graph Stat. 1996, 5: 299-314. 10.2307/1390807.Google Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.